Skip to content

Clinical Efficacy of Oral Diacerein in Ameliorating Chronified Pain and Delaying Tendon Degeneration in Rotator Cuff Injury

Clinical Efficacy of Oral Diacerein in Ameliorating Chronified Pain and Delaying Tendon Degeneration in Rotator Cuff Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121593
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tear

Interventions

Twice-Daily Diacerein Group:Take one 50 mg diacerein capsule orally in the morning and one in the evening.
Morning Diacerein Group:Take one 50 mg diacerein capsule orally in the morning.
Evening Diacerein Group:Take one 50 mg diacerein capsule orally in the evening.
Twice-Daily Control Group:Take one placebo capsule orally in the morning and one in the evening.
Morning Control Group:Take one placebo capsule orally in the morning
Evening Control Group:Take one placebo capsule orally in the evening.

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 50-70 years; (2) Shoulder pain (VAS pain score of 6 or above), accompanied by limited mobility (reduction in range of motion for abduction, elevation, internal rotation, and external rotation by 50%); (3) MRI findings indicating supraspinatus tendon degeneration with a tear less than 1 cm; (4) Symptoms of shoulder pain and limited mobility lasting no more than 3 months.

Exclusion criteria

Exclusion criteria: (1) Presence of underlying diseases such as hypertension and diabetes; (2) MRI findings indicating moderate to large tears of the supraspinatus tendon; (3) History of previous shoulder dislocation; (4) Rotator cuff injury caused by trauma; (5) Moderate to severe shoulder osteoarthritis, Hamada classification grade 3 or above.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) and Numeric Rating Scale (NRS);Specialized physical examination of the shoulder joint (range of motion; Neer sign; Hawkins sign; Empty Can Test; Drop Arm Test);Shoulder MRI examination;Surgical rate;

Countries

China

Contacts

Public ContactZhao Qichun

The First Affiliated Hospital of University of Science and Technology of China

qichunzhao@ustc.edu.cn+86 139 6505 0622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026